Clinical Trials Browser

GATA2 Deficiency, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Leukemia, Mast-Cell, Leukemia, Myeloid, Myeloproliferative Disorders, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05805605 2025-07-01

Allo HSCT Using RIC and PTCy for Hematological Diseases

Phase 2 Recruiting

56 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Leukemia, Myeloid, Leukemia, Plasma Cell, Lymphoma, Follicular, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Lymphoma, B-Cell, Marginal Zone, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT06130579 2025-06-03

Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT

Phase 2 Recruiting

35 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes

NCT06537726 2025-04-10

REDEFINE

Recruiting

130 enrolled

LymphoidOther hematologic neoplasm

Invasive Fungal Infections, Leukemia, Leukemia, Myeloid, Neutropenia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Invasive Pulmonary Aspergillosis

NCT06643962 2024-11-12

Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy

Phase NA Recruiting

83 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

NCT05963061 2024-04-09

Chronic Myeloid Leukemia (CML) Real-Life Database

Recruiting

3,500 enrolled

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

Clinical Trials

CIML NK Cells With Venetoclax for AML

ALERTCML

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

IAMFIT

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Allo HSCT Using RIC and PTCy for Hematological Diseases

Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT

REDEFINE

Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy

Chronic Myeloid Leukemia (CML) Real-Life Database